BioSpace News Archive

Pharm Country

Fosun Pharma and Henlius Entered into an Exclusive License Agreement for Serplulimab in the US

Fosun Pharma has recently entered into an exclusive license agreement with Shanghai Henlius Biotech, Inc. for the commercialisation of Henlius independently developed anti-PD-1 monoclonal antibody serplulimab in the United States.

January 7, 2023
·
10 min read
Policy

Otsuka and Lundbeck Announce FDA Acceptance and Priority Review of sNDA for Brexpiprazole for the Treatment of Agitation Associated With Alzheimer’s Dementia

Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S announce the U.S. Food and Drug Administration has determined that the supplementary New Drug Application for brexpiprazole for the use in the treatment of agitation associated with Alzheimer’s dementia is sufficiently complete to permit a substantive review.

January 7, 2023
·
7 min read